Skip to main content
NIH

Division of Genomic Medicine

A Catalog of Published Genome-Wide Association Studies


Update (5/12/15): The NHGRI-EBI GWAS Catalog has moved to the European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) at  http://www.ebi.ac.uk/gwas. Users may now find the new search interface and updated content at this site.  Questions about the GWAS Catalog may be directed to gwas-info@ebi.ac.uk.

Why has the catalog moved to EMBL-EBI?
From September 2010 to the present, delivery and development of the Catalog has been a collaborative project between EMBL-EBI and NHGRI. In March 2015 the Catalog infrastructure moved to EMBL-EBI to enable delivery of an improved user interface, including ontology driven Catalog searching, and new curatorial infrastructure, supporting improved QC processes. Catalog content available through this original GWAS Catalog website was last updated on February 20th 2015 with all previous and updated content available at EMBL-EBI. 


The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog).
Read our recent article from Nucleic Acids Research.

Published Genome-Wide Associations
Credit: Darryl Leja and Teri Manolio, NHGRI; Tony Burdett, Dani Welter, and Helen Parkinson, EBI

 
An archived tab-delimited file of the GWAS Catalog content prior to the EBI transition is available here: Tab Delimited File
 

The genome-wide association study (GWAS) publications in the Catalog include a primary GWAS analysis, defined as array-based genotyping and analysis of 100,000+ pre-QC SNPs selected to tag variation across the genome and without regard to gene content.  GWAS data from published studies which are incorporated into new GWAS analyses are eligible, provided they meet the other criteria.  Studies imputing sequencing data to genotyping arrays are eligible as long as the arrays include sufficient genome-wide coverage so that the post-imputation analysis meets the definition of a GWAS analysis, as described above. The scope of the GWAS Catalog is currently being expanded to include studies of large-scale targeted/non-genome-wide arrays, including the Metabochip, Immunochip and Exome arrays. This is currently in a pilot phase where prioritization of targeted and exome array studies for inclusion in the Catalog is by 1) relevance of the trait analyzed 2) user request.  

How to cite the NHGRI GWAS Catalog:
MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, Pendlington Z, Welter D, Burdett T, Hindorff L, Flicek P, Cunningham F, and Parkinson H. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Research, 2017, Vol. 45 (Database issue): D896-D901.

For questions or comments about this page, send an e-mail to: gwas_table@mail.nih.gov

 

 

 

 





Notice: The updated Catalog content may now be searched at http://www.ebi.ac.uk/gwas/.

An archived, tab-delimited file of the GWAS Catalog content prior to the EBI transition is available here: Tab Delimited File

Date Added to Catalog (since 11/25/08) First Author/Date/ Journal/Study Disease/Trait Initial
Sample Description
Replication Sample Description Region Reported Gene(s) Mapped Gene(s) Strongest SNP-Risk Allele Context Risk Allele Frequency in Controls P-value
OR or beta-coefficient and [95% CI]
Platform
[SNPs passing QC]
CNV
05/11/13 Del-Aguila JL
February 12, 2013
Pharmacogenomics J
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
Thiazide-induced adverse metabolic effects in hypertensive patients 425 European ancestry cases, 342 African American cases NA View full set of 59 SNPs Illumina and Affymetrics
[>2 million] (Imputed)
N
11p15.1 NELL-1 NELL1 rs12279250-C intron 0.15 7 x 10-9 (AA-triglyceride response) 28.2 [18.67-37.73] mg/dL increase
3q26.2 GOLIM4 GOLIM4 - EGFEM1P rs2686586-T 0.47 6 x 10-8 (AA-triglyceride response) 18.93 [11.89-25.97] mg/dL increase
6q24.1 GPR126 VTA1 rs225675-G intron 0.19 1 x 10-7 (AA-glucose response) 5.29 [3.35-7.23] mg/dL decrease
18p11.21 FAM38B PIEZO2 rs12455924-T intron 0.36 3 x 10-7 (AA-triglyceride response) 17.88 [11.04-24.72] mg/dL decrease
10q21.1 PCDH15 SNRPEP8 - PCDH15 rs7077606-T 0.12 5 x 10-7 (AA-glucose response) 5.44 [3.32-7.56] mg/dL decrease
5q14.3 MEF2C MEF2C; MEF2C-AS1 rs17560407-G intron;intron 0.27 5 x 10-7 (EA-triglyceride response) 23.23 [14.14-32.32] mg/dL decrease
12p13.31 GDF3 GDF3 - DPPA3 rs12307997-G 0.22 6 x 10-7 (AA-triglyceride response) 22.11 [13.41-30.81] mg/dL increase
7p12.2 CDC14C CDC14C - VWC2 rs7801534-G 0.17 7 x 10-7 (AA-glucose response) 4.96 [3.02-6.9] mg/dL increase
15q25.3 AGBL1 AGBL1; AGBL1-AS1 rs10152811-A intron;intron 0.69 8 x 10-7 (AA-triglyceride response) 18.81 [11.32-26.3] mg/dL decrease
10q11.23 ASAH2 ASAH2 - DYNC1I2P1 rs10508921-T 0.13 9 x 10-7 (AA-triglyceride response) 25.7 [15.47-35.93] mg/dL decrease




Top of page

Catalog Data Last Updated: February 20, 2015
Web Page Text Last Updated: September 16, 2015